Small intestinal bacterial overgrowth and evaluation of intestinal barrier function in patients with ulcerative colitis.

Chunchun Yang, Xueli Zhang, Suming Wang, Xiaohui Huo, Jing WangPubMed 2021

Abstract

UC patients present a higher positive rate in SIBO. Mesalazine and rifaximin are applied to patients with mild to moderate UC, and their clinical efficacy has been significantly enhanced after the eradication of SIBO.
BibTeX
@inproceedings{yang2021small,
  author = {Chunchun Yang and Xueli Zhang and Suming Wang and Xiaohui Huo and Jing Wang},
  title = {{Small intestinal bacterial overgrowth and evaluation of intestinal barrier function in patients with ulcerative colitis.}},
  booktitle = {PubMed},
  year = {2021},
}

Loading related content...

Figure